Circulating Biomarkers Conference Puts the Spotlight on miRNA, cfDNA and CTC Biomarkers in Oncology

BioteXcel is pleased to announce the Circulating Biomarkers 2014 Conference which will be held in Dundee on 1st & 2nd October. In an effort to strengthen the link between emerging technologies and personalized healthcare decision points, this conference brings together experts in the area of circulating biomarkers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend

Circulating Biomarkers 2014 Dundee

Speakers and attendees will discuss how these and other circulating biomarkers can be used to make better patient healthcare decisions.

Dundee, UK (PRWEB UK) 18 June 2014

At the Circulating Biomarkers 2014 Dundee Conference, experts will be presenting research in the areas of circulating tumour cells (CTCs), circulating micro-RNA (miRNA) and circulating free DNA (cfDNA). Speakers and attendees will discuss how these and other circulating biomarkers can be used to make better patient healthcare decisions. Speakers will consist of experts in the field, including Prof. Caroline Dive, Prof. Charles Coombes, Prof. Sean Grimmond, Prof. Jacqui Shaw, Prof. Nicol Keith, Prof. Angie Cox and others.

The conference will bring together renowned key opinion leaders along with attendees working at the cutting edge of circulating biomarker discovery research to facilitate its development into minimally invasive diagnostics that can help patients and their physicians make better healthcare decisions. Attendees will scrutinize workflows linking biomarker discovery and diagnostics to foster collaborations to help bring diagnostic tests, kits and devices into reality and further the era of true personalized medicine in oncology and other disease areas. Please click here to view the agenda.

Using a simple blood sample from a patient and analysing its circulating biomarker content we move into the domain of minimally invasive molecular tests, allowing integration of the patient perspective and medical information. Such tests can focus on specific circulating biomarkers and biomarker signatures to determine whether a patient is, or will be prone to a disease (prognostic test) or whether a patient will benefit from a given therapy (predictive test). Currently, this is still largely out of reach as most molecular tests are done on biopsies, which are often of limited availability and can lead to possible health complications for the patient. The focus of this meeting will be to look at circulating biomarkers and their clinical utility in patient care management.

Dundee City Council have kindly sponsored this conference and subsidised tourism possibilities for all registrants to this event, this will include free and discounted access to local attractions. Dundee is located in a beautiful part of the world and is easily accessible via rail, road and air with a local airport connected with direct flights to Stansted (operated by Flybe).

If you are interested in attending the conference, please contact Biotexcel or visit the Registration Page for more details and to book on-line.

This conference is organised in partnership with Abertay University. It is sponsored by Silicon Biosystems and Cambridge Bioscience. Our media partner is BioDiscovery.


Contact

Attachments

Past News Releases Group Rss Subscribe